Results 91 to 100 of about 964 (170)

Differential Response to 12 Weeks of Once-Daily Tiotropium/Olodaterol Fixed Dose Combination in Patients with COPD: A Multidimensional Response Profiling in the TORRACTO Study. [PDF]

Int J Chron Obstruct Pulmon Dis, 2023
Posthuma R, Vanfleteren LEGW, Gaffron S, Vaes AW, Franssen FME, Spruit MA.   +5 more
europepmc   +1 more source

Clinical and Economic Evaluation of Fluticasone Furoate/Umeclidinium/Vilanterol Versus Tiotropium/Olodaterol Therapy in Maintenance Treatment-Naive Patients with COPD in the US. [PDF]

Int J Chron Obstruct Pulmon Dis
Shaikh A, Ritz J, Casciano J, Palli SR, Clark B, Dotiwala Z, Quint JK.   +6 more
europepmc   +1 more source

Pulmonary Rehabilitation in Primary Care: Functional and Emotional Impact in a Patient with COPD: A Case Report. [PDF]

Reports (MDPI)
Esteves V, Gonçalves SD.
europepmc   +1 more source

Effectiveness of Tiotropium/Olodaterol in the Real World: A Post Hoc Subgroup Analysis After the First Year of Use. [PDF]

Adv Ther, 2022
Sato A, Miyazaki A, Nakamura S.
europepmc   +1 more source

A Longitudinal Assessment of Greenhouse Gas Emissions From Inhaler Devices in a National Health System. [PDF]

JAMA
Weppner WG, Singh H, Boyd J, Smith G, Chesebro BB.   +4 more
europepmc   +1 more source

Dynamic chest radiographic evaluation of the effects of tiotropium/olodaterol combination therapy in chronic obstructive pulmonary disease: the EMBODY study protocol for an open-label, prospective, single-centre, non-controlled, comparative study. [PDF]

BMJ Open Respir Res
Ikari J, Katsumata M, Urano A, Imamoto T, Suzuki Y, Nishiyama A, Yokota H, Ono K, Okamoto K, Abe E, Kamata T, Fujii S, Okumura K, Ota J, Suzuki E, Kawata N, Ozawa Y, Masuda Y, Matsushita K, Sakao S, Uno T, Tatsumi K, Suzuki T.   +22 more
europepmc   +1 more source

Rationale and Design of an Exploratory, Randomized, Open-Label, Multicenter Clinical Trial to Investigate the Efficacy of Long-Acting β2-Agonist/Long-Acting Muscarinic Antagonist on Heart Failure Complicated by Chronic Obstructive Pulmonary Disease (COPD-HF Trial). [PDF]

Circ Rep
Hayashi H, Ito S, Fukuda H, Sata M, Abe Y, Fujimoto K, Fukuda D, Hanajima Y, Horii M, Ikehara N, Inoko M, Izumi C, Izumiya Y, Nakayama T, Sozu T, Toyoda S, Watanabe M, Yokoi M, Kitakaze M.   +18 more
europepmc   +1 more source

Evaluation of comparative efficacy of Umeclidinium/Vilanterol versus other bronchodilators in the management of chronic obstructive pulmonary disease: a systematic review and meta-analysis of RCTs. [PDF]

BMC Pulm Med
Zhu H, Lei J, Gao F, Guo Y, Zhao L.
europepmc   +1 more source

Pharmacologic Therapies for Preventing Chronic Obstructive Pulmonary Disease Exacerbations: A Comprehensive Review. [PDF]

Tuberc Respir Dis (Seoul)
Lee HW.
europepmc   +1 more source

Assessing the impact of implementing the clinical protocol and therapeutic guidelines in COPD in real-life. [PDF]

Clinics (Sao Paulo)
Sales DAL, Honório PCM, Pinto VB, Fernandes FLA, Pinto RMC, Cukier A.   +5 more
europepmc   +1 more source